Evaluation of Below-the-Knee Drug-Eluting Stents With Frequency-Domain Optical Coherence Tomography: Neointimal Hyperplasia and Neoatherosclerosis

Journal of Endovascular Therapy - Tập 20 Số 1 - Trang 80-93 - 2013
Ioannis Paraskevopoulos1, Stavros Spiliοpoulos1, Periklis Davlouros2, Dimitrios Karnabatidis1, Konstantinos Katsanos1, Dimitrios Alexopoulos2, Dimitrios Siablis1
1#N# 1Department of Diagnostic and Interventional#N# Radiology, Patras University Hospital, Patras, Greece.
2#N# 2Department of Cardiology, Patras University#N# Hospital, Patras, Greece.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Karnabatidis D, Spiliopoulos S, Katsanos K, et al. Below-the-knee drug-eluting stents and drug-coated balloons.Expert Rev Med Devices. 2012;9:85–94.

Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization.Circulation. 2007;116:2072–2085.

Karnabatidis D, Spiliopoulos S, Diamantopoulos A, et al. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia.J Endovasc Ther. 2011;18:1–12.

Siablis D, Karnabatidis D, Katsanos K, et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome.J Vasc Interv Radiol. 2009;20:1141–1150.

Rastan A, Tepe G, Krankenberg H, et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial.Eur Heart J. 2011;32:2274–2281.

Kang SJ, Mintz GS, Park DW, et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis.Am J Cardiol. 2010;106:1561–1565.

Park SJ, Kang SJ, Virmani R, et al. In-stent neoatherosclerosis: a final common pathway of late stent failure.J Am Coll Cardiol. 2012;59:2051–2057.

Takano M, Yamamoto M, Inami S, et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography.J Am Coll Cardiol. 2009;55:26–32.

Bezerra HG, Costa MA, Guagliumi G, et al. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications.JACC Cardiovasc Interv. 2009;2:1035–1046.

Davlouros P, Damelou A, Karantalis V, et al. Evaluation of culprit saphenous vein graft lesions with optical coherence tomography in patients with acute coronary syndromes.JACC Cardiovasc Interv. 2011;4:683–693.

Kang SJ, Mintz GS, Akasaka T, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.Circulation. 2011;123:2954–2963.

Karnabatidis D, Katsanos K, Paraskevopoulos I, et al. Frequency-domain intravascular optical coherence tomography of the femoropopliteal artery.Cardiovasc Intervent Radiol. 2011;34:1172–1181.

Tsantis S, Kagadis GC, Katsanos K, et al. Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography.Med Phys. 2012;39:503–513.

Setacci C, de Donato G, Setacci F, et al. Safety and feasibility of intravascular optical coherence tomography using a nonocclusive technique to evaluate carotid plaques before and after stent deployment.J Endovasc Ther. 2012;19:303–11.

Meissner OA, Rieber J, Babaryka G, et al. Intravascular optical coherence tomography: differentiation of atherosclerotic plaques and quantification of vessel dimensions in crural arterial specimens [in German].Rofo. 2006;178:214–220.

Meissner OA, Rieber J, Babaryka G, et al. Intravascular optical coherence tomography: comparison with histopathology in atherosclerotic peripheral artery specimens.J Vasc Interv Radiol. 2006;17:343–349.

Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography.Circulation. 2002;106:1640–1645.

Rieber J, Meissner O, Babaryka G, et al. Diagnostic accuracy of optical coherence tomography and intravascular ultrasound for the detection and characterization of atherosclerotic plaque composition in ex-vivo coronary specimens: a comparison with histology.Coron Artery Dis. 2006;17:425–430.

Teramoto T, Ikeno F, Otake H, et al. Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment.Circ J. 2010;74:1257–1259

Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy.J Am Coll Cardiol. 2007;50:933–939.

Kotani J, Awata M, Nanto S, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.J Am Coll Cardiol. 2006;47:2108–2111.

Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.J Vasc Surg. 2012;55:390–398.

Katsanos K, Spiliopoulos S, Krokidis M, et al. Does below-the-knee placement of drug-eluting stents improve clinical outcomes?J Cardiovasc Surg (Torino). 2012;53:195–203.

Rastan A, Brechtel K, Krankenberg H, et al. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial.J Am Coll Cardiol. 2012;60:587–591.

Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues.J Endovasc Ther. 2009;16(Suppl I):I153–I162.

Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents.J Am Coll Cardiol. 2011;57:1314–1322.

Hou J, Qi H, Zhang M, et al. Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomography study.Heart. 2010;96:1187–1190.

Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage.Arterioscler Thromb Vasc Biol. 2005;25:2054–2061.

Kim BK, Kim JS, Shin DH, et al. Optical coherence tomography evaluation of in-stent restenotic lesions with visible microvessels.J Invasive Cardiol. 2012;24:116–120.

Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).J Vasc Surg. 2007;45 Suppl S:S5–67.

Higo T, Ueda Y, Oyabu J, et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.JACC Cardiovasc Imaging. 2009;2:616–624.

Davlouros PA, Karantalis V, Xanthopoulou I, et al. Mechanisms of non-fatal stent-related myocardial infarction late following coronary stenting with drug-eluting stents and bare metal stents. Insights from optical coherence tomography.Circ J. 2011;75:2789–2797.